Evoke Pharma, Inc. announced that its abstract entitled “Real-World Healthcare Resource Utilization of Patients Treated with Metoclopramide Nasal for Diabetic Gastroparesis (DGP)” will be presented at the Academy of Managed Care Pharmacy (AMCP) annual meeting taking place in San Antonio, TX from March 21-24, 2023. GIMOTI is the first and only FDA-approved novel nasal formulation of metoclopramide that is commercially available and specifically designed to deliver a non-oral dose of metoclopramide for the relief of symptoms in adults with acute and recurrent DGP. Prior to GIMOTI's approval by the U.S. Food and Drug Administration (FDA), oral metoclopramide was the only FDA-approved outpatient treatment for patients suffering from DGP.

The poster presentation at the AMCP annual meeting will cover the data from a retrospective cohort analysis of 294 patients receiving nasal metoclopramide (GIMOTI). The study was designed to evaluate whether GIMOTI reduced the need for doctor's office, emergency department, inpatient, and outpatient visits across all settings for patients using GIMOTI versus the period prior to GIMOTI initiation. Lead author, Dr. David C. Kunkel, Gastroenterologist and Associate Professor of Medicine at UC San Diego Health, emphasized the challenges faced by patients with gastroparesis who have limited treatment options and often experience flare-ups.

“Gastroparesis flares lead to numerous emergency care visits and hospitalizations due to dehydration, malnutrition, or glucose control problems, and as a result, the cost of care for these patients is substantial. The nasal delivery option provides a novel method of treating gastroparesis that allows healthcare providers to directly dose medication to patients whose timing of absorption for oral medications can be unpredictable. Details of the poster presentation are as follows: Poster Title: Real-World Healthcare Resource Utilization of Patients Treated with Metoclopramide Nasal for Diabetic Gastroparesis (DGP); Presentation Date/Time: March 23 from 11:30 a.m. – 2:30 p.m. CST; Location: Henry B. Gonzalez Convention Center, San Antonio, TX; Poster No: K2.